Pilot and Repeat Trials as Development Tools Associated with Demonstration of Bioequivalence

Journal Title: The AAPS Journal - Year 2015, Vol 17, Issue 3

Abstract

The online version of this article (doi:10.1208/s12248-015-9744-6) contains supplementary material, which is available to authorized users.

Authors and Affiliations

Anders Fuglsang

Keywords

Related Articles

Squarticles as a Lipid Nanocarrier for Delivering Diphencyprone and Minoxidil to Hair Follicles and Human Dermal Papilla Cells

Delivery of diphencyprone (DPCP) and minoxidil to hair follicles and related cells is important in the treatment of alopecia. Here we report the development of “squarticles,” nanoparticles formed from seb...

Novel Hybrid GPU–CPU Implementation of Parallelized Monte Carlo Parametric Expectation Maximization Estimation Method for Population Pharmacokinetic Data Analysis

The development of a population PK/PD model, an essential component for model-based drug development, is both time- and labor-intensive. A graphical-processing unit (GPU) computing technology has been proposed and used t...

Study Reanalysis Using a Mechanism-Based Pharmacokinetic/Pharmacodynamic Model of Pramlintide in Subjects with Type 1 Diabetes

This report describes a pharmacokinetic/pharmacodynamic model for pramlintide, an amylinomimetic, in type 1 diabetes mellitus (T1DM). Plasma glucose and drug concentrations were obtained following bolus and 2-h intraveno...

Selectivity and potency of cyclin-dependent kinase inhibitors

Members of the cyclin-dependent kinase (CDK) family play key roles in various cellular processes. There are 11 members of the CDK family known till now. CDKs are activated by forming noncovalent complexes with cyclins su...

Pharmacokinetics, Lymph Node Uptake, and Mechanistic PK Model of Near-Infrared Dye-Labeled Bevacizumab After IV and SC Administration in Mice

The online version of this article (doi:10.1208/s12248-012-9342-9) contains supplementary material, which is available to authorized users.

Download PDF file
  • EP ID EP680953
  • DOI  10.1208/s12248-015-9744-6
  • Views 48
  • Downloads 0

How To Cite

Anders Fuglsang (2015). Pilot and Repeat Trials as Development Tools Associated with Demonstration of Bioequivalence. The AAPS Journal, 17(3), -. https://europub.co.uk./articles/-A-680953